- Home
- UTHR vs SBS Comparison
UTHR vs SBS Comparison
Compare UTHR & SBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- SBS
- Stock Information
- Founded
- UTHR 1996
- SBS 1954
- Country
- UTHR United States
- SBS Brazil
- Employees
- UTHR N/A
- SBS N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- SBS Water Supply
- Sector
- UTHR Health Care
- SBS Utilities
- Exchange
- UTHR Nasdaq
- SBS Nasdaq
- Market Cap
- UTHR 13.4B
- SBS 13.2B
- IPO Year
- UTHR 1999
- SBS 2002
- Fundamental
- Price
- UTHR $294.28
- SBS $19.52
- Analyst Decision
- UTHR Buy
- SBS
- Analyst Count
- UTHR 13
- SBS 0
- Target Price
- UTHR $379.69
- SBS N/A
- AVG Volume (30 Days)
- UTHR 547.4K
- SBS 1.2M
- Earning Date
- UTHR 07-30-2025
- SBS 08-11-2025
- Dividend Yield
- UTHR N/A
- SBS 2.80%
- EPS Growth
- UTHR 17.94
- SBS 184.67
- EPS
- UTHR 25.63
- SBS 2.61
- Revenue
- UTHR $3,077,800,000.00
- SBS $6,629,708,013.00
- Revenue This Year
- UTHR $14.37
- SBS N/A
- Revenue Next Year
- UTHR $6.59
- SBS $14.25
- P/E Ratio
- UTHR $11.48
- SBS $7.51
- Revenue Growth
- UTHR 17.62
- SBS 43.80
- 52 Week Low
- UTHR $266.98
- SBS $13.87
- 52 Week High
- UTHR $417.82
- SBS $22.18
- Technical
- Relative Strength Index (RSI)
- UTHR 49.57
- SBS 42.99
- Support Level
- UTHR $272.12
- SBS $18.93
- Resistance Level
- UTHR $307.71
- SBS $19.78
- Average True Range (ATR)
- UTHR 8.47
- SBS 0.43
- MACD
- UTHR -1.25
- SBS -0.05
- Stochastic Oscillator
- UTHR 62.26
- SBS 43.24
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About SBS Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (Each repstg 250)
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.